CMS Finalizes Drastic 340B Reimbursement Cut for 2018.
نویسنده
چکیده
CMS finalizes drastic 340B reimbursement cut for 2018.
منابع مشابه
Provider Reimbursement Following the Affordable Care Act.
Decreasing health care expenditures has been one of the main objectives of the Affordable Care Act. To achieve this goal, the Centers for Medicare and Medicaid Services (CMS) has been tasked with experimenting with provider reimbursement methods in an attempt to increase quality, while decreasing costs. The purpose of this research was to study the effects of the Affordable Care Act on physicia...
متن کاملHow the sequester cuts are harming oncology.
The Centers for Medicare and Medicaid Services (CMS) has applied the sequestration cuts to oncology in a drastic manner that grossly amplifies the magnitude of an already-problematic 2% cut. While CMS claims it is “unaware of any authority” to exempt cancer drugs from the sequester cuts,[2] it is likely that the agency could have mitigated the impact. CMS used its discretion to apply the 2% seq...
متن کاملPolicy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
Congress established Section 340B of the Public Health Service Act—commonly referred to as the 340B Drug Pricing Program—in 1992.1 The 340B Drug Pricing Program requires manufacturers to provide substantial discounts for sales of covered drugs to covered entities as a prerequisite to qualifying for Medicaid reimbursement. Covered hospitals and other covered entities must limit the use of discou...
متن کاملHospital Group Wants to Expand Section 340B Drug Purchase Program.
the House Ways and Means Committee on September 23. He explained that this would allow the hospitals to further stretch their limited resources and relieve them of the burden of carrying two separate inventories and pricing structures for inpatient and outpatient drugs. Theoretically, the Ways and Means Committee, in conjunction with Energy and Commerce and Senate Finance, could initiate author...
متن کاملFinal Rule on ACOs Raises Concerns About Medication Cost-Shifting: Pharmacists to Play a Secondary Role in New Physician-Hospital Organizations.
the Academy of Managed Care Pharmacy. Of course, the number of program integrity “watchdogs” at the CMS and other federal health agencies is decreasing, with federal budget cuts being the order of the day. Even in the halcyon days of federal spending with bigger staffs, Department of Health and Human Services watchdogs were rather passive policemen. The Office of Pharmacy Affairs, which adminis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 43 1 شماره
صفحات -
تاریخ انتشار 2018